National Heart Lung & Blood Institute
This article was originally published in The Gray Sheet
Executive Summary
Phase I grant to Implant Sciences covers development of a "radioactive coronary stent with multiple half lives." The device will utilize two radioactive isotopes "providing longer range radioisotopes at each end that will provide a higher dose of radiation beyond the ends of the stent" to help prevent restenosis, the Wakefield, Massachusetts firm says